@article{37e9071e17de4b72a6fa549f9a11e3af,
title = "Clinical and genetic characterization of adult-onset leukoencephalopathy caused by CSF1R mutations",
abstract = "Objective: Mutations in the colony-stimulating factor 1 receptor gene (CSF1R) were identified as a cause of adult-onset inherited leukoencephalopathy. The present study aims at investigating the frequency, clinical characteristics, and functional effects of CSF1R mutations in Taiwanese patients with adult-onset leukoencephalopathy. Methods: Mutational analysis of CSF1R was performed in 149 unrelated individuals with leukoencephalopathy by a targeted resequencing panel covering the entire coding regions of CSF1R. In vitro analysis of the CSF1-induced autophosphorylation activities of mutant CSF1R proteins was conducted to assess the pathogenicity of the CSF1R mutations. Results: Among the eight CSF1R variants identified in this study, five mutations led to a loss of CSF1-induced autophosphorylation of CSF1R proteins. Four mutations (p.K586*, p.G589R, p.R777Q, and p.R782C) located within the tyrosine kinase domain of CSF1R, whereas the p.T79M mutation resided in the immunoglobulin-like domain. The five patients carrying the CSF1R mutations developed cognitive decline at age 41, 43, 50, 79, and 86 years, respectively. Psychiatric symptoms and behavior changes were observed in four of the five patients. The executive function and processing speed were severely impaired at an early stage, and their cognitive function deteriorated rapidly within 3–4 years. Diffusion-restricted lesions at the subcortical regions and bilateral corticospinal tracts were found in three patients. Interpretation: CSF1R mutations account for 3.5% (5/149) of the adult-onset leukoencephalopathy in Taiwan. CSF1R mutations outside the tyrosine kinase domain may also disturb the CSF1R function and lead to the clinical phenotype. Molecular functional validation is important to determine the pathogenicity of novel CSF1R variants.",
author = "Tsai, {Pei Chien} and Fuh, {Jong Ling} and Yang, {Chih Chao} and Anna Chang and Lien, {Li Ming} and Wang, {Pei Ning} and Lai, {Kuan Lin} and Tsai, {Yu Shuen} and Lee, {Yi Chung} and Liao, {Yi Chu}",
note = "Funding Information: This study was supported by the grants from the Ministry of Science and Technology, Taiwan (107‐2314‐B075‐014‐MY3, 109‐2628‐B075‐025), Taipei Veterans General Hospital (V106D21‐004‐MY2, V108C‐076), and Brain Research Center, National Yang‐Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan. We thank the GenoInfo Core Facility (C1) funded by the National Core Facility Program of MOST Taiwan (MOST109‐2740‐B‐010‐002) for providing bioinformatics supports. Funding Information: This study was supported by the grants from the Ministry of Science and Technology, Taiwan (107-2314-B075-014-MY3, 109-2628-B075-025), Taipei Veterans General Hospital (V106D21-004-MY2, V108C-076), and Brain Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan. We thank the GenoInfo Core Facility (C1) funded by the National Core Facility Program of MOST Taiwan (MOST109-2740-B-010-002) for providing bioinformatics supports. This study was supported by the grants from the Ministry of Science and Technology, Taiwan (107-2314-B075-014-MY3, 109-2628-B075-025), Taipei Veterans General Hospital (V106D21-004-MY2, V108C-076), and Brain Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan. We thank the GenoInfo Core Facility (C1) funded by the National Core Facility Program of MOST Taiwan (MOST109-2740-B-010-002) for providing bioinformatics supports. We also thank the Clinical and Industrial Genomic Application Development Service Center funded by National Core Facility Program for Biotechnology, Taiwan (MOST 107-2319-B-010-002) for sequencing. Funding Information: This study was supported by the grants from the Ministry of Science and Technology, Taiwan (107‐2314‐B075‐014‐MY3, 109‐2628‐B075‐025), Taipei Veterans General Hospital (V106D21‐004‐MY2, V108C‐076), and Brain Research Center, National Yang‐Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan. We thank the GenoInfo Core Facility (C1) funded by the National Core Facility Program of MOST Taiwan (MOST109‐2740‐B‐010‐002) for providing bioinformatics supports. We also thank the Clinical and Industrial Genomic Application Development Service Center funded by National Core Facility Program for Biotechnology, Taiwan (MOST 107‐2319‐B‐010‐002) for sequencing. Publisher Copyright: {\textcopyright} 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association",
year = "2021",
month = nov,
doi = "10.1002/acn3.51467",
language = "English",
volume = "8",
pages = "2121--2131",
journal = "Annals of Clinical and Translational Neurology",
issn = "2328-9503",
publisher = "John Wiley and Sons Ltd",
number = "11",
}